Efficacy of Sentinel Lymph Node Biopsy in Male Breast Cancer

Journal of Surgical Oncology

Volumn 86, Issue 2, 2004, Pages 74-77

  Cimmino, Vincent M ^a,b   Degnim, Amy C ^a   Sabel, Michael S ^a   Diehl, Kathleen M ^a   Newman, Lisa A ^a   Chang, Alfred E ^a  

^a UNIVERSITY OF MICHIGAN COMPREHENSIVE CANCER CENTER   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Axillary lymph node dissection (ALND); Ductal carcinoma in situ (DCIS); Estrogen receptor (ER); Sentinel lymph node biopsy (SLNB)

Indexed keywords

ESTROGEN RECEPTOR; ISOSULFAN BLUE; RADIOISOTOPE; TECHNETIUM SULFUR COLLOID TC 99M;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CLINICAL ARTICLE; FROZEN SECTION; HUMAN; LYMPH NODE BIOPSY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHOSCINTIGRAPHY; MALE; MALE BREAST; NEEDLE BIOPSY; PRIORITY JOURNAL; SENTINEL LYMPH NODE; TUMOR VOLUME;

AXILLA; BREAST NEOPLASMS, MALE; CARCINOMA, DUCTAL, BREAST; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; MASTECTOMY; MIDDLE AGED; NEOPLASM STAGING; RECEPTORS, ESTROGEN; SENTINEL LYMPH NODE BIOPSY;

EID: 2342509099     PISSN: 00224790     EISSN: None     Source Type: Journal    
DOI: 10.1002/jso.20045     Document Type: Article

References (16)

1. Jemal A, Murray T, Samuels A, et al.: Cancer statistics 2003. CA Cancer J Clin 2003;53:5-26.
2. Veronesi U, Pagnelli G, Galimbertic V, et al.: Sentinel node biopsy to avoid axillary dissection in breast cancer with clinical negative nodes. Lancet 1997;349:1864-1867.
3. Fisher B, Ravdin RG, Ausman RK, et al.: Surgical adjuvant chemotherapy in cancer of the breast: Results of a decade of cooperative investigation. Ann Surg 1968;168:337.
4. Borgen PI, Wong Y, Vlams V, et al.: Current management of male breast cancer, a review of 104 cases. Ann Surg 1994;215: 451-459.
5. Petrek JA, Blackwood MM: Axillary dissection: Current practice and technique. Curr Prob Surg 1995;XXXII:309-316.
6. Guilano AE, Kugan DM, Guenther JM, et al.: Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 1994;220:391-401.
7. Veronesi U, Paganelli G, Viale G, et al.: Sentinel node biopsy and axillary dissection in breast cancer: Results in a large series. J Natl Cancer Inst 1999;91:368-373.
8. Krag D, Weaver D, Ashikaga T.: The sentinel node in breast cancer - A multicenter validation study. N Engl J Med 1998;339: 941-946.
9. Giuliano AE, Dale PS, Turner RR, et al.: Improved axillary staging of breast cancer with sentinel lymphadenectomy. Ann Surg 1995;222:394-399.
10. Port ER, Fey JV, Cody HS III, et al.: Sentinel lymph node biopsy in patients with male breast carcinoma. Cancer 2001;91: 319-323.
11. Anelli A, Anelli TFM, Youngson B, et al.: Mutations of the P53 gene in male breast cancer. Cancer 1995;75:2233-2238.
12. Borgen PI: Male breast cancer. Semin Surg Oncol 1991;7: 314-319.
13. Olson JA, Fey J, Winauver J, et al.: Sentinel lymphadectomy accurately predicts nodal status in T2 breast cancer. J Am Coll Surg 2000;191:593-599.
14. Fitzgibbons PL, Page DL, Weaver D, et al.: Prognostic factors in breast cancer. College of American pathologists consensus statement 1999. Arch Pathol Lab Med 2000;124: 966-978.
15. Mullan MH, Kissin MW: Positive sentinel node biopsy in male breast carcinoma. ANZ J Surg 2001;71:438-440.
16. Anderson WF, Chu KC, Chatterjee N, et al.: Male breast cancer in the SEER database. Am Soc Clin Oncol 2001;(Abstract no): 1691.